It is not a disease you catch. It is five measurements that, taken together, predict trouble better than any one of them alone.
Metabolic syndrome is a cluster, not a disease. The definition in use internationally comes from a 2009 joint statement by the International Diabetes Federation, the American Heart Association and several others, which harmonised what had been three competing definitions.
You meet it if any three of the following five are present. Being on treatment for one of them counts as having it.
| Criterion | Threshold |
|---|---|
| Waist circumference | Population and country specific |
| Triglycerides | 150 mg/dL (1.7 mmol/L) or above |
| HDL cholesterol | Below 40 mg/dL in men, below 50 in women |
| Blood pressure | 130 systolic or 85 diastolic, or above |
| Fasting glucose | 100 mg/dL (5.6 mmol/L) or above |
Waist circumference is the only criterion without a single universal number, and it is the one people query most. The reason is that fat distribution differs by ancestry: the waist at which metabolic risk rises is lower in South and East Asian populations than in European ones, and the thresholds are set per population rather than pretending otherwise.
It is measured rather than weighed because the question is not how much fat you carry but where. Fat around the organs — visceral fat — is metabolically active in a way that fat under the skin is not. Two people at the same weight and height can be on opposite sides of this line.
Notice that none of the five numbers is a diagnosis on its own. A fasting glucose of 100 is not diabetes. A blood pressure of 130/85 is not hypertension in most guidelines. An HDL of 39 would pass without comment on its own.
That is the whole point. Each criterion is set at the level where risk begins to rise, not where disease is declared. The syndrome exists to catch the pattern years before any single number becomes alarming — and the pattern predicts cardiovascular disease and type 2 diabetes better than any one of its components alone.
The common thread through most cases is insulin resistance. Muscle and liver respond less well to insulin, the pancreas compensates by producing more, and the raised insulin itself drives several of the five: it promotes fat storage around the organs, raises triglycerides, lowers HDL, and contributes to sodium retention and blood pressure.
This is why the criteria travel together rather than appearing at random. They are five visible consequences of one largely invisible process, and it is the process that treatment aims at.
Meeting three criteria does not mean you will develop diabetes or have a heart attack. It means you are in a group with raised probability of both, and that the window in which the trajectory can be changed is open now.
It is also not a verdict on character. Insulin resistance has strong genetic and age-related components, and the five numbers above are measurements, not a report card.
Four of the five come from a standard panel and a blood pressure cuff. The fifth needs a tape measure, taken at the midpoint between the lowest rib and the top of the hip bone, at the end of a normal breath out.
If you already have recent bloodwork, you can count your own criteria in about a minute. What to do about the count is a conversation with a physician, and it depends considerably on which three they are.
Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.
Measure my biomarkers